# Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying

> **NCT02160990** · PHASE4 · COMPLETED · sponsor: **Mayo Clinic** · enrollment: 20 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Exenatide
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02160990
- **Lead sponsor:** Mayo Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-06
- **Primary completion:** 2015-03
- **Final completion:** 2015-03
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02160990

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02160990, "Effect of Exenatide in Obese Patients With Accelerated Gastric Emptying". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02160990. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*